VEXAS Syndrome Latest Advances

Find the Latest Research About VEXAS Syndrome

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 635 publications

VEXAS syndrome with atypical presentation: A case report and review of eosinophils in cutaneous biopsies.

VEXAS syndrome with atypical presentation: A case report and review of eosinophils in cutaneous biopsies.

Journal: JAAD case reports
Published: June 24, 2026

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: June 22, 2026

The inflammatory "death-to-life" loop in VEXAS syndrome.

The inflammatory "death-to-life" loop in VEXAS syndrome.

Journal: Blood
Published: June 11, 2026

Ophthalmic Artery Vasculitis in VEXAS Syndrome: A Novel, Vision-Threatening Manifestation.

Ophthalmic Artery Vasculitis in VEXAS Syndrome: A Novel, Vision-Threatening Manifestation.

Journal: Ocular immunology and inflammation
Published: May 20, 2026

Drug-Free Remission of VEXAS Syndrome Without Stem Cell Transplantation.

Drug-Free Remission of VEXAS Syndrome Without Stem Cell Transplantation.

Journal: Cureus
Published: May 17, 2026

Systemic inflammation with myelodysplastic features: VEXAS syndrome.

Systemic inflammation with myelodysplastic features: VEXAS syndrome.

Journal: BMJ case reports
Published: May 13, 2026

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

Journal: American journal of hematology
Published: May 12, 2026

Pneumocystis prophylaxis in rheumatic disease.

Pneumocystis prophylaxis in rheumatic disease.

Journal: Best practice & research. Clinical rheumatology
Published: May 11, 2026

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026

Necrotizing Fasciitis Caused by ESBL-Producing Raoultella ornithinolytica in an Immunocompromised Patient with VEXAS Syndrome.

Necrotizing Fasciitis Caused by ESBL-Producing Raoultella ornithinolytica in an Immunocompromised Patient with VEXAS Syndrome.

Journal: Acta medica Okayama
Published: April 23, 2026

A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome.

A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome.

Journal: Frontiers in medicine
Published: April 17, 2026

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Showing 1-12 of 635

Last Updated: 06/30/2026